ESB - Latin American Society for Biomaterials, Tissue Engineering and Artificial Organs (SLABO) Joint Symposium
Title Symposium: Development of New Biomaterials with Multifunctional Surfacess
Biomaterials field is growing in the last decades due to the increased life expectancy of the world population. Nowadays, the study of biomaterials has been extended to several areas with a focus on the volume and surface properties. Thus, the discussion of advances in new materials with multifunctional surfaces becomes strategic to our area.
Proposed Program:
The session focuses on the structure/property/function and processing relationship of biomaterials.
Proponent 1 / Chair / Keynote Speaker 2:
Prof. Dr. Ana Paula Rosifini Alves Claro
Unesp, Sao Paulo State University, School of Engineering, Guaratingueta, Brazil
Proponent 2 / Co-Chair:
Prof. Dr. Miguel Oliveira
Institute 3Bs, University of Minho, Guimaraes, Portugal
Keynote Speaker 1:
Prof. Dr. Juilietta V. Rau
Institute of the Structure of Matter, Italian National Research Council, Rome, Italy
Juilietta V. Rau, Prof. Dr.
Title of the talk:
New trends in multifunctional surface modification of stable and biodegradable biomedical implants.
Julietta V. Rau (Dr, PhD, Prof.) is currently Principal Investigator, Head of the laboratory and research group at the Institute of the Structure of Matter of the Italian National Research Council (ISM-CNR, Rome, Italy) and Associate Professor at the Sechenov First Moscow State Medical University (Moscow, Russia).
Dr. Rau has authored +160 international peer-reviewed journal publications and presented her research as Invited and Plenary talks at +30 International Conferences.
She supervised PhD and MSc students and is involved in mentoring of postdoctoral research fellows.
Dr. Rau received several international awards for her research achievements.
She is the CHAIR and organizer of the biennial BioMaH âBiomaterials and Novel Technologies for Healthcareâ International Conference (https://biomah.ism.cnr.it) and the Member of the International Scientific Committees of various International Conferences in the field of Materials Science, Nanoscience, Biomaterials and Medical devices.
Dr. Rau is Associate Editor of the Bioactive Materials journal and the Member of the Editorial Boards of numerous scientific journals.
Her present research interests regard biomaterials and novel technologies for healthcare, innovative biomaterials for regenerative medicine, among them calcium phosphates and glass-ceramic based materials for tissue engineering applications. One of her research topics is focussed on coatings for biomedical implant applications and, namely, on nanostructured coatings for orthopaedic and dental implants, which are developed via an interdisciplinary international collaborative network team.
https://www.researchgate.net/profile/Julietta_Rau
http://orcid.org/0000-0002-7953-1853
Ana Paula Rosifini Alves Claro, Pfrof. Dr.
SĂŁo Paulo State University, School of Engineering, Materials and Technology Department, GuaratinguetĂĄ – SP – Brazil
Ana Paula Rosifini Alves Claro, Ph.D., FSBE, is currently Principal Investigator, Head of the laboratory for Development of New Biomedical Materials, and Full Professor at the São Paulo State University (UNESP). Dr. Alves Claro has over twenty years of experience in the field of Biomaterials. She was elected Vice-president of SLABO in 2018. Dr. Alves Claro is a member of the Editorial Board In vitro Models. In the last years, she supervised Ph.D. and MSc students and is involved in mentoring postdoctoral research fellows.
ESB - Chinese Society for Biomaterials (CSBM) Joint Symposium
Title symposiumïŒFrontiers of Materiobiology
Materiobiology is a scientific discipline proposed by Changshen Liu in 2017 [Chemical Reviews 117(5)], that studies the biological effects of the properties of biomaterials on biological functions at different levels (e.g., cells, tissues, organs, and the whole organism). The presentation of this new concept further highlights and motivates the synergism between cell biology and biomaterial technologies that jointly accelerate the clinical and commercial translation of biomaterials. This symposium will share recent progress on how biomaterials with controllable properties (e.g., compositional/degradable dynamics, mechanical properties, 2D topography, and 3D geometry) can regulate cell behavior and tissue/organ functions. The symposium will also highlight the rapid growth of high-throughput methodologies to study the combinative materiobiology cues to cell behavior and tissue regeneration, among other concepts.
Proponent 1 / Chair:
Prof. Ji Jian
Position Director of the Institute of Biomedical Macromolecules, Department of Polymer Science and Engineering, Zhejiang University, Zhejiang, China
Proponent 2 / Co-Chair:
Prof. Dr. Aldo R. Boccaccini
Department of Materials Science and Engineering, University of Erlangen-Nuremberg, Erlangen, Germany
Keynote Speaker 1:
Prof. Liu Changsheng
Cheung Kong Scholar, Professor of biomaterials
President of Shanghai University
Chairman-elect of Chinese Society for Biomaterials
Keynote Speaker 2:
Prof. Matthew Dalby
Institute of Molecular Cell & Systems Biology, University of Glasgow, UK
Changsheng Liu, Prof. Dr.
Shanghai University, Academician of Chinese Academy of Sciences, Shanghai, China
Changsheng Liu , PhD, Professor of Shanghai University, Academician of Chinese Academy of Sciences. Dr. Liu is director of Engineering Research Center for Biomaterial Materials of Ministry of EducationïŒdirector of Key Laboratory for Ultrafine Materials of Ministry of Education etc..
Dr. Liu has interdisciplinary academic background of biology and materials engineering. He has devoted for decades into the fundamental and application research of biological materials. His major research areas include biomaterials and tissue regeneration; fabrication of inductive growth factors and designing of bioactive skeletal substitutes for bone repair; and nano-biomaterials as well. Dr. Liu has obtained a few outstanding achievements in the field of biomaterials. He has published 5 books and more than 290 papers, including the TOP journal of the field, such as Chem Rev, Sci AdvăBiomaterials, Adv Mater, Adv Func Mater, and Acta Biomater, etc. Moreover, he has also applied 65 invention patents including 4 US patents. He developed a few novel biomaterials and got the approval from CFDA, and now widely used in clinic application. He achieved international Fellow of Biomaterials Science and Engineering (2012), American Institute for Medical and Biological Engineering (AIMBE) FellowïŒ2018ïŒïŒand Ho Leung Ho Lee Foundation-Prize for Scientific and Technological Innovation Award (2007). Furthermore, he won the Second-prize of National Award for Natural Science in 2014, the Second-prize of National Award for Science and Technology Progress in 2003.
ESB-Controlled Release Society (CRS) Joint Symposia
Title of the Symposium: Biomaterials for Drug Delivery Applications
Nano/micro-biomaterials have a crucial impact in development of novel drug delivery systems for different biomedical engineering and regenerative medicine applications. This symposium aims to provide an overview of how the precise engineering of biomaterials (e.g., inorganic, organic, and hybrid materials) can lead to target delivery of drugs to cells and to promote tissue engineering.
Proposed program:Â
The session focuses on multifunctional biomaterials for controlled drug delivery and biomedical applications.
Proponent 1 / Chair:
Prof. HĂ©lder A. Santos
University of Helsinki, Finland
Proponent 2 / Co-Chair:
Dr. Carmen Sofia da Rocha Freire
CICECO/University of Aveiro, Portugal
Keynote Speaker 1:Â
Prof Jesus M De la Fuente
University of Zaragoza, Spain
Keynote 1 title:Â
Nanoactuators for Therapy and Diagnosis
Keynote Speaker 2:Â
Prof. Horacio Cabral
University of Tokyo, Japan
Keynote 2 title:
Nanomedicine Strategies for Targeted Delivery of Challenging Therapeutics
JesĂșs MartĂnez de la Fuente, Prof. Dr.
Prof.  JesĂșs MartĂnez de la Fuente (Barakaldo, 1975) created his own research group (BIONANOSURF Group) at the Univ of Zaragoza in 2007, becoming internationally recognized in nanomaterials and biofunctionalization. The multidisciplinary nature of the group facilitates research and development in numerous areas, including biosensors, gene therapy, magnetism, photochemistry, surface chemistry and molecular metal oxides, among others. He has extensive experience in the synthesis and characterization of novel nanomaterials and their biofunctionalization for the use and development of the next generation of nanobiosensors and nanotherapeutics. In 2009, he founded the spin-off Nanoimmunotech SL. He has also been a pioneer in the application of gold nanoparticles in gene therapy and he has developed a methodology for the use of gold nanoparticles functionalized with carbohydrates (glyconanoparticles) for the study of biological processes (embryogenesis, cancer, inflammation, etc.). He has been PI of research projects with a total budget of more than 6 MâŹ. 75% of this budget is derived from European projects (1 ERANET (Coord); 1 ERC-StG (Coord), 1 ERC-POC (Coord), 7 MSCA-IOF/IEF/IF (Coord), 1 ENMII, 1 TRANSCANII (Coord), 1 FP7, 3 H2020-NMBP); 10% comes from collaborations with companies (CASEN-FLEET, ORPHAN DRUG-RECORDATI, MECWINS, NB, NIT, PROTEOMIKA, BSH, VIRBAC); and the remaining 15% comes from research projects of national calls. In 2010 he was awarded the AragĂłn Investiga prize „Young Researchers“. In 2013 he was awarded by the Shanghai Administration with the 1000 Talent Plan program to be a visiting professor at the Jiao Tong University of Shanghai. Since 2014, he is a permanent researcher at the Instituto de Nanociencia y Materiales de Aragon-CSIC.
Horacio Cabral, Prof. Dr.
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Japan
Horacio Cabral is an Associate Professor in the Department of Bioengineering, Graduate School of Engineering, The University of Tokyo. He received his Ph.D. in Materials Engineering from The University of Tokyo in 2007 under the supervision of Prof. Kazunori Kataoka. Dr. Cabral was an Assistant Professor at the Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, until 2010, when he joined the Department of Bioengineering of The University of Tokyo as a Lecturer. In 2014, he was promoted to his current position.
Dr. Cabralâs major research interests relate to the development of nanomedicines for diagnosis and therapy, particularly systems directed to intractable cancers. He has made major influential achievements in the development of translatable polymeric nanocarriers Particularly, his polymeric micelles targeting anticancer drugs to tumors have proceeded into human clinical studies, improving patientsâ survival and reducing side effects. Moreover, he has accomplished seminal contributions in the understanding of the effect of nanocarrier design on activity, particularly through intratumoral and intracellular navigation. He has published more than 100 articles in refereed journals, including Nature Nanotechnology, Nature Reviews Clinical Oncology, Science Translational Medicine, PNAS, etc., and he is inventor of more than 30 patents.
Dr. Cabral has been recipient of several awards, such as the Asahi Glass Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research. He currently serves on the editorial board of Science and Technology of Advanced Materials, and Nanomaterials, and the advisory board of Macromolecular Bioscience and MedChem.
ESB â Society for Biomaterials (SFB) Joint Symposium
Title symposium: Immunomodulatory Biomaterials
Immune cells play pivotal roles in tissue repair, responses to biomedical implants and tissue grafts, and defense against pathogens. Recent biomaterials efforts have centered on engineering materials to modulate immune cells for targeted regenerative responses. This symposium will highlight emerging biomaterial-based approaches to immune therapies.
Proponent 1 / Chair:
Prof. Dr. Andrés Garcia
Executive Director, Parker H. Petit Institute for Bioengineering and Bioscience; Regentsâ Professor, George W. Woodruff School of Mechanical Engineering; Georgia Institute of Technology; USA
Proponent 2 / Co-Chair:
Prof. Dr. Abhay Pandit
Established Professor in Biomaterials, Director, CĂRAM â SFI Research Center for Medical Devices, National University of Ireland, Galway, Ireland
Keynote Speaker 1:
Prof. Dr. Andrés Garcia
Keynote Talk 1:
Hydrogels for Immune Acceptance of Transplanted Pancreatic Islets
Keynote Speaker 2:
Prof. Dr. Willem Mulder
Professor of Precision Medicine at the Department of Biomedical Engineering, Eindhoven University of Technology, The Netherlands
Keynote Title 2: To be announcedÂ
